CU-02

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCU-02
Drug Alias NameCU-02
ClassificationOther
Mechanisms of ActionTryptophan hydroxylase 1 inhibitors
TargetsTryptophan hydroxylase 1
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCuracle Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCuracle Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A